| WANBURY  | 
The Current P/B Ratio of WANBURY  is 17.86.
                
| Share Price | ₹263.2 | Oct 31,2025 | 
| Market Cap | ₹918.4 Cr | |
| Book Value | ₹51.4 Cr | Mar2025 - Consolidated Results | 
| Price/Book | 17.86x | Calculated as MarketCap/Book Value | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
                    P/B = 
                    Market Capitalization 
                    / Book Value 
                    
                    or, using per-share numbers:
                    
                    P/B = Stock Price / 
                    Book Value Per Share 
                
               
                                     Current Market Cap [ ₹918.4 Cr] as on Oct 31,2025                     
                    (/) Book Value [ ₹51.4 Cr] based on Mar2025 - Consolidated Results
                                    
                
                (=) P/B Ratio [ 17.86x ]
            
Thus, for WANBURY , the investors are currently willing to pay '17.86 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.30x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2024 at 22.63x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap | 
|---|---|---|---|
| WANBURY | 51.41 | 17.86 | 918.4 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.61 | 405,452.0 | 
| DIVIS LABORATORIES LTD | 14,969.00 | 11.96 | 179,089.0 | 
| CIPLA LTD | 31,079.30 | 3.90 | 121,299.0 | 
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 15.87 | 120,456.0 | 
| DR REDDYS LABORATORIES LTD | 33,404.90 | 2.99 | 99,965.9 | 
| MANKIND PHARMA LTD | 14,288.70 | 6.88 | 98,333.5 | 
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.09 | 98,057.5 | 
| LUPIN LTD | 17,119.50 | 5.24 | 89,722.4 | 
| AUROBINDO PHARMA LTD | 32,653.30 | 2.03 | 66,133.0 | 
| ABBOTT INDIA LTD | 4,204.27 | 14.66 | 61,629.9 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
| Top 10 Industry Peers | PB Ratio | 
|---|---|
| Min industry PB | 2.03x | 
| Max industry PB | 17.86x | 
| Median industry PB | 5.61x | 
| Average industry PB | 8.28x | 
You may also like the below Video Courses
 
                                     
                                     
                                    